Sheinfeld J. The rola of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concept and contraversies. Semin Clin Oncol. 2002;262–71.
2.
Argirovic D. Late reccurences of germ cell testicular tumours. A population based experience over 23 years. Eur Urol Meet. 2007;(5):38.
3.
Argirovic D. Late relapse of germ cell testicular tumors following cisplatin-based chemotherapy. Eur Urol Meet. 2007;(7):138.
4.
Loehrer Pj Sr, Hui S, Clarck S, Seal M, Einhorn L, Williams S. Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathologic consideration. J Urol. 1986;1183–9.
5.
Sonneveld D, Sleijfer D, Koops H, Keemers-Gels M, Molenaar W, Hoeckstra H. Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an agressive surgical approach. Cancer. 1998;1343–51.
6.
Baniel J, Foster R, Messemer G, Donohue J, Einhorn J, L. Late relapse of testicular cancer. J clin Oncol. 1995;1170–6.
7.
Lipphardt M, Albers P. Late relapse of testicular cancer. World J Urol. 2004;47–54.
8.
Argirovic D, Stanic V, Argirovic A. The impact of residual extra-retroperitoneal masses in patients with advanced nonseminomatous testicular tumors. Eur Urol Meet. 2009;(8):625.
9.
A prognostic factor-based staging system for metastatic germ cell cancer. J Clin Oncol. 1987;594–603.
10.
Toner G, Panicek D, Heelan R, Galler N, Lin SY, Bajorin D. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol. 1990;1683–94.
11.
Carver B, Shayegan B, Motzer S, Bosl R, Sheinfeld G, J. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma. J Clin Oncol. 2007;1033–7.
12.
Svatek R, Spiess P, Sundi D, Tu S, Tannir N, Brown G. Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection. Cancer. 2009;1310–7.
13.
Wood D, Herr H, Heller G. Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. J Urol. 1992;1812–5.
14.
Steiner H, Peschel R, Bartsch G. Retroperitoneal lymph node dissection after chemotherapy for germ cell tumours: is a full bilateral template always necessary? BJU Int. 2008;262–71.
15.
Heidenreich A, Pfister D, Wittluhn R, Thuer D, Albers P. Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection. Eur Urol. 2009;217–24.
16.
Pettus J, Carver B, Masterson T, Stasi J, Sheifeld J. Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer. Urology. 2009;328–31.
17.
Rabbani F, Goldenberg S, Gleave M, Paterson R, Murray N, Sullivan L. Retroperitoneal lymphadenectomy for postchemotherapy residual masses: is a modified dissection and resection of residual masses sufficient? Br J Urol. 1998;295–300.
18.
Aprikian A, Herr H, Bajorin D, Bosl G. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic germ cell tumors. Cancer. 1994;1329–34.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
